Successful Treatment of Crizotinib-Induced Fulminant Liver Failure: A Case Report and Review of Literature

Crizotinib is a first-line tyrosine kinase inhibitor used for the treatment of metastatic lung cancer. Crizotinib-induced hepatotoxicity is a rare event. We report a case of a 46-year-old female with a history of metastatic lung cancer who presented with acute liver failure after being on crizotinib...

Descripción completa

Detalles Bibliográficos
Autores principales: Kreitman, Kyle, Nair, Satheesh P., Kothadia, Jiten P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7085870/
https://www.ncbi.nlm.nih.gov/pubmed/32231818
http://dx.doi.org/10.1155/2020/8247960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7085870/
https://www.ncbi.nlm.nih.gov/pubmed/32231818
http://dx.doi.org/10.1155/2020/8247960

Ejemplares similares